89 related articles for article (PubMed ID: 6822738)
1. Activation of the classical pathway of human complement by a human monoclonal IgE, IgE(DES).
Saint-Remy JM; Magnusson CG; Masson PL
J Immunol; 1983 Mar; 130(3):1341-4. PubMed ID: 6822738
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
Saint-Remy JM
Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
[TBL] [Abstract][Full Text] [Related]
3. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
Füst G; Medgyesi GA; Rajnavölgyi E; Csécsi-Nagy M; Czikora K; Gergely J
Immunology; 1978 Dec; 35(6):873-84. PubMed ID: 104923
[TBL] [Abstract][Full Text] [Related]
4. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
5. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
Doekes G; van Es LA; Daha MR
Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
[TBL] [Abstract][Full Text] [Related]
6. Repressed classical complement pathway activities and clinical correlations in chronic lymphocytic leukaemia.
Miszlai Z; Czink E; Varga L; Pálóczi K; Szegedi G; Füst G; Hollán SR
Acta Med Hung; 1986; 43(4):389-95. PubMed ID: 3601584
[TBL] [Abstract][Full Text] [Related]
7. Classical pathway of complement activation in mammalian kidneys.
Zwirner J; Felber E; Burger R; Bitter-Suermann D; Riethmüller G; Feucht HE
Immunology; 1993 Oct; 80(2):162-7. PubMed ID: 8262545
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
Beebe DP; Schreiber RD; Cooper NR
J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
[TBL] [Abstract][Full Text] [Related]
9. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
[TBL] [Abstract][Full Text] [Related]
10. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
Doekes G; van Es LA; Daha MR
J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
[TBL] [Abstract][Full Text] [Related]
11. C4 does not bind to human and rabbit IgM during activation of the classical complement pathway on the red cell.
Circolo A; Borsos T
J Immunol; 1982 Oct; 129(4):1485-8. PubMed ID: 7108214
[TBL] [Abstract][Full Text] [Related]
12. Unusual complement activation properties of serum immunoglobulins of the pigeon Columba livia.
Koppenheffer TL; Russell BA
Immunology; 1986 Mar; 57(3):473-8. PubMed ID: 3957409
[TBL] [Abstract][Full Text] [Related]
13. Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1-2a monovalent anti-TNP antibody bound to TNP-conjugated cells.
Couderc J; Kazatchkine MD; Ventura M; Duc HT; Maillet F; Thobie N; Liacopoulos P
J Immunol; 1985 Jan; 134(1):486-91. PubMed ID: 3917282
[TBL] [Abstract][Full Text] [Related]
14. Activation of first component of complement (C1) in guinea pig serum by a polysaccharide is prevented by C1 inhibitor.
Schultz DR; Arnold PI
J Immunol; 1981 Apr; 126(4):1558-61. PubMed ID: 7204976
[TBL] [Abstract][Full Text] [Related]
15. Kinetic measurement of the interaction of rheumatoid factor with IgG-coated latex particles and the influence of the first component of human complement.
Hällgren R
Clin Exp Immunol; 1980 Jan; 39(1):154-63. PubMed ID: 6771071
[TBL] [Abstract][Full Text] [Related]
16. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
[TBL] [Abstract][Full Text] [Related]
17. Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.
Lambre CR; Thibon M; Le Maho S; Di Bella G
Immunology; 1983 Jun; 49(2):311-9. PubMed ID: 6852870
[TBL] [Abstract][Full Text] [Related]
18. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
[TBL] [Abstract][Full Text] [Related]
19. Activation of the classical and alternate pathways of complement by Corynebacterium parvum.
McBride WH; Weir DM; Kay AB; Pearce D; Caldwell JR
Clin Exp Immunol; 1975 Jan; 19(1):143-7. PubMed ID: 1204238
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
